Page last updated: 2024-08-21

2-piperidone and belinostat

2-piperidone has been researched along with belinostat in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, MG; Ihm, SH; Kang, JG; Kim, CS; Kim, SH; Lee, SJ; Yoo, HJ	1

Other Studies

1 other study(ies) available for 2-piperidone and belinostat

Article	Year
Gemigliptin, a novel dipeptidyl peptidase-IV inhibitor, exerts a synergistic cytotoxicity with the histone deacetylase inhibitor PXD101 in thyroid carcinoma cells. Journal of endocrinological investigation, 2018, Volume: 41, Issue:6 Topics: Apoptosis; Biomarkers, Tumor; Cell Survival; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Piperidones; Pyrimidines; Signal Transduction; Sulfonamides; Thyroid Neoplasms; Tumor Cells, Cultured	2018

Article

Year

Gemigliptin, a novel dipeptidyl peptidase-IV inhibitor, exerts a synergistic cytotoxicity with the histone deacetylase inhibitor PXD101 in thyroid carcinoma cells.

Journal of endocrinological investigation, 2018, Volume: 41, Issue:6

Topics: Apoptosis; Biomarkers, Tumor; Cell Survival; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Piperidones; Pyrimidines; Signal Transduction; Sulfonamides; Thyroid Neoplasms; Tumor Cells, Cultured

2018